Integrated BioPharma, Inc. (INBP)
OTCMKTS: INBP · Delayed Price · USD
0.220
+0.003 (1.38%)
May 14, 2024, 1:46 PM EDT - Market closed

Integrated BioPharma Income Statement

Millions USD. Fiscal year is Jul - Jun.
Year 20232022202120202019 2018 - 1996
Revenue
50.6756.2563.5652.7749.98
Upgrade
Revenue Growth (YoY)
-9.91%-11.51%20.45%5.59%14.34%
Upgrade
Cost of Revenue
46.6149.6954.0846.0443.76
Upgrade
Gross Profit
4.066.559.486.736.22
Upgrade
Selling, General & Admin
3.943.813.73.473.52
Upgrade
Other Operating Expenses
0.04-0.090.06-0.27-0.02
Upgrade
Operating Expenses
3.943.813.73.473.52
Upgrade
Operating Income
0.121.975.782.382.7
Upgrade
Interest Income
0.010.130.260.40.63
Upgrade
Interest Expense
0.040.110.260.40.63
Upgrade
Other Expense / Income
-0.01-0.61-1.46-0.70.66
Upgrade
Pretax Income
0.12.67.253.092.04
Upgrade
Income Tax
0.13-1.24-0.77-1.020.35
Upgrade
Net Income
-0.033.848.014.111.69
Upgrade
Net Income Growth
--52.10%95.06%143.36%148.60%
Upgrade
Shares Outstanding (Basic)
3030303029
Upgrade
Shares Outstanding (Diluted)
3032323130
Upgrade
Shares Change
-7.34%0.65%3.07%5.31%-2.41%
Upgrade
EPS (Basic)
-0.000.130.270.140.06
Upgrade
EPS (Diluted)
-0.000.120.250.130.06
Upgrade
EPS Growth
--52.00%92.31%128.07%154.46%
Upgrade
Free Cash Flow
1.123.612.761.13-0.09
Upgrade
Free Cash Flow Per Share
0.040.110.090.04-0.00
Upgrade
Gross Margin
8.01%11.65%14.92%12.75%12.45%
Upgrade
Operating Margin
0.24%3.50%9.10%4.52%5.41%
Upgrade
Profit Margin
-0.07%6.82%12.61%7.78%3.38%
Upgrade
Free Cash Flow Margin
2.20%6.41%4.33%2.13%-0.17%
Upgrade
Effective Tax Rate
134.00%-47.79%-10.57%-33.03%17.34%
Upgrade
EBITDA
1.32.86.673.163.46
Upgrade
EBITDA Margin
2.57%4.98%10.49%5.98%6.92%
Upgrade
Depreciation & Amortization
1.150.830.830.770.77
Upgrade
EBIT
0.151.975.842.382.69
Upgrade
EBIT Margin
0.29%3.50%9.19%4.52%5.37%
Upgrade
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.